Nothing Special   »   [go: up one dir, main page]

ES2203615T3 - Nucleosidos terapeuticos. - Google Patents

Nucleosidos terapeuticos.

Info

Publication number
ES2203615T3
ES2203615T3 ES93904248T ES93904248T ES2203615T3 ES 2203615 T3 ES2203615 T3 ES 2203615T3 ES 93904248 T ES93904248 T ES 93904248T ES 93904248 T ES93904248 T ES 93904248T ES 2203615 T3 ES2203615 T3 ES 2203615T3
Authority
ES
Spain
Prior art keywords
mixture
amino
methanol
formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93904248T
Other languages
English (en)
Spanish (es)
Inventor
Susan Mary Daluge
Douglas Alan Livingston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2203615T3 publication Critical patent/ES2203615T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES93904248T 1992-02-25 1993-02-24 Nucleosidos terapeuticos. Expired - Lifetime ES2203615T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929204015A GB9204015D0 (en) 1992-02-25 1992-02-25 Therapeutic nucleosides
GB9204015 1992-02-25

Publications (1)

Publication Number Publication Date
ES2203615T3 true ES2203615T3 (es) 2004-04-16

Family

ID=10711016

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93904248T Expired - Lifetime ES2203615T3 (es) 1992-02-25 1993-02-24 Nucleosidos terapeuticos.

Country Status (14)

Country Link
US (5) US5641889A (fr)
EP (1) EP0628044B1 (fr)
JP (1) JP3172533B2 (fr)
KR (1) KR100282584B1 (fr)
AT (1) ATE245646T1 (fr)
AU (2) AU3571093A (fr)
CA (1) CA2130755C (fr)
DE (1) DE69333109T2 (fr)
DK (1) DK0628044T3 (fr)
ES (1) ES2203615T3 (fr)
GB (1) GB9204015D0 (fr)
HK (1) HK1003941A1 (fr)
PT (1) PT628044E (fr)
WO (1) WO1993017020A2 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
CA2001401A1 (fr) * 1988-10-25 1990-04-25 Claude Piantadosi Derives d'ether ou d'ester lipidique contenant une amine quaternaire et composes therapeutiques
GB9204015D0 (en) 1992-02-25 1992-04-08 Wellcome Found Therapeutic nucleosides
DE69431596D1 (de) * 1993-06-10 2002-11-28 Wake Forest University Winston (phospho)lipide zum bekämpfen einer hepatitis b-infektion
DE69402548T2 (de) 1993-06-21 1997-07-17 Merrell Pharma Inc Carbocyclische nucleoside mittel nützlich als selektive inhibitoren von proinflammatorischen cytokinen
EP0630897A3 (fr) * 1993-06-25 1995-03-01 Bristol Myers Squibb Co 3-Hydroxy-4-hydroxyméthyl-2-methylène-cyclopentyl purines et pyrimidines.
WO1995022330A1 (fr) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Agents antiviraux
ATE395922T1 (de) 1994-08-29 2008-06-15 Univ Wake Forest Lipid-analoge zur behandlung von viralen infektionen
US7135584B2 (en) 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
AU3170597A (en) 1996-05-30 1998-01-05 Lonza A.G. Process for the preparation of amino alcohols and derivatives thereof
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
SK284810B6 (sk) * 1997-05-13 2005-12-01 Lonza Ag Spôsob výroby (1S,4R)- alebo (1R,4S)-4-(2-amino-6-chlór-9-H- purín-9-yl)-2-cyklopentén-1-metanolu
CZ298144B6 (cs) * 1997-11-27 2007-07-04 Lonza Ag Zpusob výroby (1S,4R)- nebo (1R,4S)-4-(2-amino-6-chlor-9-H-purin-9-yl)-2-cyklopenten-1-methanolu
US6362225B1 (en) * 1999-01-21 2002-03-26 George Andreakos Target therapies for treating common viral infections
US6514979B1 (en) 1999-03-03 2003-02-04 University Of Maryland Biotechnology Institute Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor
YU25500A (sh) 1999-05-11 2003-08-29 Pfizer Products Inc. Postupak za sintezu analoga nukleozida
WO2001018003A1 (fr) * 1999-09-10 2001-03-15 Stichting Rega Vzw Nucleosides carbocycliques et procede de production correspondant
US7026469B2 (en) 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
WO2002032885A1 (fr) * 2000-10-18 2002-04-25 Kuraray Co., Ltd. Preparation d'esters d'acide amino-2-aza-1-oxybicyclo[3.3.0]oct-2-ene-6-carboxylique 4-n substitues et preparation de leurs produits intermediaires
GB2378180B8 (en) 2001-06-27 2009-10-21 Cyclacel Ltd New purine derivatives
GB0219052D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New puring derivatives
CA2463719A1 (fr) 2003-04-05 2004-10-05 F. Hoffmann-La Roche Ag Analogues de nucleotides possedant des cycles a six chainons
GB0320738D0 (en) * 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
WO2005075426A1 (fr) * 2004-02-03 2005-08-18 Glenmark Pharmaceuticals Ltd. Nouveaux inhibiteurs de dipeptidyle peptidase iv, leur procedes de preparation et compositions en comportant
US7230002B2 (en) 2004-02-03 2007-06-12 Glenmark Pharmaceuticals Ltd. Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
US20070208042A1 (en) 2006-03-03 2007-09-06 Sherwood Services Ag Method of using vasoconstrictive agents during energy-based tissue therapy
US7767686B2 (en) * 2006-03-03 2010-08-03 Covidien Ag Method of using adenosine receptor blockers during tissue ablation
KR101925902B1 (ko) * 2007-08-02 2018-12-06 밀레니엄 파머슈티컬스 인코퍼레이티드 E1 활성화 효소 억제제의 합성 방법
EP2326627A1 (fr) * 2008-08-20 2011-06-01 Schering Corporation Dérivés de pyridine et pyrimidine substituées et leur utilisation dans le traitement d'infections virales
TW201020245A (en) 2008-08-20 2010-06-01 Schering Corp Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
JP5654990B2 (ja) 2008-08-20 2015-01-14 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. アゾ置換ピリジンおよびピリミジン誘導体ならびにそれらのウイルス感染の治療における使用
JP5619743B2 (ja) 2008-08-20 2014-11-05 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. エテニル置換ピリジンおよびピリミジン誘導体およびウイルス感染の治療におけるそれらの使用
LT3127542T (lt) 2010-01-27 2018-11-26 Viiv Healthcare Company Antivirusinė terapija
EP2697983A1 (fr) 2011-04-14 2014-02-19 Phonak AG Instrument auditif
GB201513601D0 (en) * 2015-07-31 2015-09-16 Univ Liverpool Antiviral compounds
CN106220515A (zh) * 2016-08-12 2016-12-14 郸城巨鑫生物科技有限公司 一种(1r,4s)‑1‑氨基‑4‑羟甲基‑2‑环戊烯盐酸盐的合成方法
JP7084591B2 (ja) * 2017-03-29 2022-06-15 ヤマサ醤油株式会社 ヌクレオシド誘導体又はその塩、及びそれを含む医薬組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60139653A (ja) * 1983-12-27 1985-07-24 Yoshitomi Pharmaceut Ind Ltd シクロペンテン誘導体
US4543255A (en) * 1984-05-10 1985-09-24 Southern Research Institute Carbocyclic analogs of purine 2'-deoxyribofuranosides
EP0219838A3 (fr) * 1985-10-22 1988-04-06 Takeda Chemical Industries, Ltd. Nucléosides de purine carbocycliques, leur préparation et leur utilisation
IN164556B (fr) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
US4734194A (en) * 1986-03-25 1988-03-29 The Upjohn Company Combined filter and valve mechanism
IN166499B (fr) * 1987-02-12 1990-05-19 Takeda Chemical Industries Ltd
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
EP0452360A4 (en) * 1988-12-12 1992-05-20 Peter M. Palese Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
ATE118208T1 (de) * 1989-10-16 1995-02-15 Chiroscience Ltd Chirale azabicycloheptanone und verfahren zu ihrer herstellung.
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
JPH04505768A (ja) * 1990-03-06 1992-10-08 ヴィラケム・インコーポレーテッド サイトメガロウイルス感染の予防および治療のための方法および組成物
GB9204015D0 (en) 1992-02-25 1992-04-08 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
AU707075B2 (en) 1999-07-01
ATE245646T1 (de) 2003-08-15
US5808147A (en) 1998-09-15
EP0628044B1 (fr) 2003-07-23
US6392085B2 (en) 2002-05-21
EP0628044A1 (fr) 1994-12-14
CA2130755A1 (fr) 1993-08-26
JPH07504185A (ja) 1995-05-11
DE69333109T2 (de) 2004-04-15
GB9204015D0 (en) 1992-04-08
CA2130755C (fr) 2004-03-30
WO1993017020A2 (fr) 1993-09-02
US5840990A (en) 1998-11-24
DE69333109D1 (de) 2003-08-28
PT628044E (pt) 2003-12-31
WO1993017020A3 (fr) 1994-03-17
JP3172533B2 (ja) 2001-06-04
AU3571093A (en) 1993-09-13
AU2489197A (en) 1997-08-28
KR950700298A (ko) 1995-01-16
DK0628044T3 (da) 2003-11-17
US5919941A (en) 1999-07-06
HK1003941A1 (en) 1998-11-13
US5641889A (en) 1997-06-24
KR100282584B1 (ko) 2001-02-15
US20010008946A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
ES2203615T3 (es) Nucleosidos terapeuticos.
US5089500A (en) Therapeutic nucleosides
PT96321B (pt) Processo para a preparacao de nucleosidos de purina
ES2211965T3 (es) Quinolonas y su utilizacion terapeutica.
KR20140054068A (ko) 테노포비어 알라펜아미드 헤미푸마레이트
US9884872B2 (en) Organic compounds
OA10610A (en) Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists.
RU2141952C1 (ru) Замещенные бензимидазольные соединения, способы получения и фармацевтическая композиция на их основе, обладающая антивирусным действием
US10196396B2 (en) Compounds antagonizing A3 adenosine receptor, method for preparing them, and medical-use thereof
JP2024520132A (ja) 向知性薬としてのline-1阻害剤
JP2023500662A (ja) イタコネートおよびメチルイタコネートの新規プロドラッグ
CZ71297A3 (en) Antiviral nucleoside analogs containing substituted benzimidazole base being attached to a carbocyclic ring, process of their preparation, pharmaceutical composition containing thereof and use
CN114555608B (zh) 草酰胺取代的乙型肝炎病毒三环抑制剂
HU211577A9 (hu) Terápiás nukleozidok Az átmeneti oltalom az 1 -20. igénypontokra vonatkozik.
NZ620421B2 (en) Tenofovir alafenamide hemifumarate